| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 56.361 | 138.998 | 115.852 | 86.501 | 150.988 | 140.001 | 93.097 |
| Total Income - EUR | - | - | - | 56.361 | 139.094 | 116.605 | 86.817 | 161.770 | 141.109 | 94.984 |
| Total Expenses - EUR | - | - | - | 21.820 | 40.135 | 69.243 | 44.138 | 134.443 | 82.524 | 83.849 |
| Gross Profit/Loss - EUR | - | - | - | 34.541 | 98.959 | 47.362 | 42.679 | 27.327 | 58.585 | 11.134 |
| Net Profit/Loss - EUR | - | - | - | 33.977 | 97.566 | 46.215 | 41.915 | 25.796 | 57.173 | 9.543 |
| Employees | - | - | - | 1 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Mg Biotech S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 93.785 | 123.334 | 118.426 | 249.357 | 227.844 | 210.418 |
| Current Assets | - | - | - | 41.492 | 194.233 | 108.247 | 117.295 | 142.676 | 153.961 | 246.955 |
| Inventories | - | - | - | 3.408 | 8.188 | 10.282 | 35.305 | 31.788 | 31.852 | 31.948 |
| Receivables | - | - | - | 6.723 | 85.869 | 38.869 | 71.935 | 66.248 | 95.888 | 95.912 |
| Cash | - | - | - | 31.361 | 100.176 | 59.097 | 10.055 | 44.640 | 26.221 | 119.095 |
| Shareholders Funds | - | - | - | 34.020 | 129.030 | 172.799 | 210.882 | 237.332 | 294.245 | 293.666 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 7.472 | 158.987 | 58.782 | 24.839 | 154.701 | 87.559 | 163.707 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7112 - 7112" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Mg Biotech S.r.l.